Kliinilises uuringus
A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration
haigus
Haiguse tüüp
Muu
Harva kasutatavate ravimite äratundmine
Jah
Patsiendi tüüp
Täiskasvanud
Lapsed
Kaasamine / välistamine
Rahastamine
era-
Kaasatud liikmed
Teised uurijad

Dr Laura Mauring
Eesti

Dr Philipp Herrmann
Saksamaa

Pr Martin Spitzer
Saksamaa

Dr Johannes Birtel
Saksamaa

Pr Katarina Stingl
Saksamaa

Dr Susanne KOHL
Saksamaa

Dr Giacomo Maria Bacci
Itaalia

Pr Francesca Simonelli
Itaalia

Pr Francesco Testa
Itaalia
ERN EYE liige uurib saiti
HCP: peamised uurijad

Tartu University Hospital, Estonia
Adress
Ludvig Puusepa 8
50406 Tartu
Estonia

Fondation Adolphe de Rothschild, Paris, France
Adress
25-29 Rue Manin
75019 Paris
France

University of Bonn, Germany
Adress
Ernst-Abbe-Strasse 2
53127 Bonn
Germany

Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany
Adress
Martinistraße 52
20251 Hamburg
Germany

Klinikum der Universität München, Germany
Adress
Mathildenstraße 8
80336 Munich
Germany

Centre for Ophthalmology, University Eye Hospital, Tübingen, Germany
Adress
Department für Augenheilkunde Tübingen Forschungsinstitut für Augenheilkunde Elfriede-Aulhorn-Str. 7
72076 Tübingen
Germany

Department of Ophthalmology Semmelweis University, Budapest, Hungary
Adress
Mária u. 39
1085 Budapest
Hungary

AOU Careggi – AOU Meyer Consortium, Firenze, Italy
Adress
Largo Brambilla 3
50134 Florence
Italy

AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy
Adress
Via Santa Maria di Costantinopoli
104, 80138 Napoli NA
Italy

University Hospital Graz, Department of Neuro-Ophthalmology, Graz, Austria
Adress
Auenbruggerplatz 4
8036 Graz
Austria